Enzolytics Inc (ENZC)

[santjers]

I am beginning to think that with today's news about toxicity tests completed in Bulgaria for the ITV-1 peptide used against an Influenza virus (and compared with Tamiflu®), with the previous news release informing us that BTS Research in San Diego is retesting the toxicity of the ITV-1 compound for the FDA's requirements, and the NIH Director's information sheet (dated today) discussing the future development of an oral COVID drug that works similar to Tamiflu®, we just may have a new class of drugs coming from a new class of small, agile Pharma companies, like our Enzolytics.

See the discussion a few paragraphs below ACTIV-5:

https://directorsblog.nih.gov/2021/02/16/activ-update-making-major-strides-in-covid-19-therapeutic-development/